Form 8-K for CELGENE CORP /DE/
Change in Directors or Principal Officers, Financial Statements and Exhibits
ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS.
On April 15, 2015, Celgene Corporation (the “Company”) announced the election of Michael W. Bonney to its Board of Directors effective on April 14, 2015. As a member of the Company’s Board of Directors, Mr. Bonney will receive an annual fee of $75,000. In addition, under the Company’s 2008 Stock Incentive Plan, on April 14, 2015, the Company granted to Mr. Bonney a non-qualified option to purchase 10,000 shares of the Company’s common stock. The option will vest in four equal annual installments commencing on the first anniversary of the date of grant.
Attached hereto and incorporated herein by reference as Exhibit 99.1 is the Press Release announcing the election of Mr. Bonney to the Board of Directors.
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.Exhibit 99.1 – Press Release dated April 15, 2015 announcing the election of Mr. Michael W. Bonney to the Company’s Board of Directors.